Vidium (6/2/2022)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} {{webinarsregistrationpage::race_approved}} true 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Vidium {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

In this webinar, explore the clinical application of cancer genomics in canine melanoma. The presentation will begin with an overview of the frequently identified mutations in canine melanoma, followed by a focus on the common therapeutic biomarkers associated with targeted therapies and a deep dive into palbociclib.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} Become familiar with the mutations commonly identified in canine melanoma and their clinical significance Learn the diagnostic and prognostic utility of mutation information in the clinical management of canine melanoma Understand the canine-specific information for palbociclib, the first in Vidium’s series of targeted therapies, including its pharmacokinetic and toxicology data {{webinarsregistrationpage::what_youll_learn_bullet_4}} {{webinarsregistrationpage::what_youll_learn_bullet_5}} {{webinarsregistrationpage::what_youll_learn_bullet_6}} {{webinarsregistrationpage::additional_subhead}} {{webinarsregistrationpage::additional_copy}} In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.